✨ Your Portfolio is fetched and updated from zerodha.
Nano Hospitals
Market Cap
₹31 Cr.
P/E
15.47
  • Nidan Labs. & Health
  • Krsnaa Diagnostics
  • Vimta Labs

FAQs on Nidan Laboratories And Healthcare Ltd. Shareprice

Nidan Labs. & Health has given lower returns compared to its competitors.
Nidan Labs. & Health has grown at ~-22.14% over the last 4yrs while peers have grown at a median rate of 1.91%

Yes, Nidan Labs. & Health is expensive.
Latest PE of Nidan Labs. & Health is 15.47, while 3 year average PE is 8.78.
Also latest EV/EBITDA of Nidan Labs. & Health is 5.29 while 3yr average is 4.92.

Growth Table

  • Nidan Laboratories And Healthcare Ltd.
  • Krsnaa Diagnostics
  • Vimta Labs

Balance Sheet

  • Nidan Laboratories And Healthcare Ltd.
  • Krsnaa Diagnostics
  • Vimta Labs

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Nidan Laboratories And Healthcare Ltd.
  • Krsnaa Diagnostics
  • Vimta Labs

Cash Flow

  • Nidan Laboratories And Healthcare Ltd.
  • Krsnaa Diagnostics
  • Vimta Labs

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Nidan Laboratories And Healthcare Ltd.
  • Krsnaa Diagnostics
  • Vimta Labs

Quarterly Results

  • Nidan Laboratories And Healthcare Ltd.
  • Krsnaa Diagnostics
  • Vimta Labs

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*

FAQs on Nidan Laboratories And Healthcare Ltd. Financials

Balance sheet of Nidan Labs. & Health is moderately strong.

Yes, The net debt of Nidan Labs. & Health is increasing.
Latest net debt of Nidan Labs. & Health is ₹10.7 Crs as of Sep-25.
This is greater than Mar-25 when it was ₹9.18 Crs.

Yes, profit is increasing.
The profit of Nidan Labs. & Health is ₹2.31 Crs for TTM, ₹1.98 Crs for Mar 2025 and -₹3.23 Crs for Mar 2024.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Nidan Labs. & Health latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech